KalVista Pharmaceuticals, Inc.
KALV
46 insider filings · Latest: Jun 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 10 10:47 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 6,693 | $16.08 | $107.6K | 451,815(D) | View → |
| Feb 23, 2026 | Feb 25 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Sale | 5,354 | $15.57 | $83.3K | 138,983(D) | View → |
| Feb 23, 2026 | Feb 25 12:44 AM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 10,034 | $15.57 | $156.2K | 442,883(D) | View → |
| Feb 23, 2026 | Feb 25 12:43 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Sale | 4,347 | $15.57 | $67.7K | 226,701(D) | View → |
| Feb 23, 2026 | Feb 25 12:42 AM | Nicole SweenyChief Commercial Officer | Sale | 3,975 | $15.57 | $61.9K | 47,003(D) | View → |
| Feb 23, 2026 | Feb 25 12:42 AM | Brian PiekosChief Financial Officer | Sale | 1,767 | $15.57 | $27.5K | 13,762(D) | View → |
| Feb 18, 2026 | Feb 20 12:45 AM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 1,038 | $15.00 | $15.6K | 429,667(D) | View → |
| Feb 18, 2026 | Feb 20 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Sale | 1,163 | $15.00 | $17.4K | 133,087(D) | View → |
| Feb 18, 2026 | Feb 20 12:44 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Sale | 1,109 | $15.00 | $16.6K | 224,173(D) | View → |
| Feb 12, 2026 | Feb 13 9:05 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 3,354 | $15.70 | $52.7K | 428,286(D) | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | May 26 11:33 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 6,250 | — | 68,750(D) | View → |
| May 21, 2026 | May 26 11:32 PM | Brian PiekosChief Financial Officer | Option Exercise | 5,000 | — | 55,000(D) | View → |
| May 17, 2026 | May 19 8:05 PM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Option Exercise | 1,774 | — | 0(D) | View → |
| May 17, 2026 | May 19 8:04 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 2,419 | — | 0(D) | View → |
| May 17, 2026 | May 19 8:03 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 2,419 | — | 0(D) | View → |
| May 11, 2026 | May 13 8:25 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 7,120 | — | 92,560(D) | View → |
| Apr 16, 2026 | Apr 20 11:42 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 6,250 | — | 93,750(D) | View → |
| Apr 16, 2026 | Apr 20 11:41 PM | Nicole SweenyChief Commercial Officer | Option Exercise | 6,250 | — | 93,750(D) | View → |
| Apr 16, 2026 | Apr 20 11:40 PM | Brian PiekosChief Financial Officer | Option Exercise | 6,250 | — | 93,750(D) | View → |
| Apr 16, 2026 | Apr 20 11:40 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 20,312 | — | 304,688(D) | View → |
| Mar 6, 2026 | Mar 10 10:47 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 15,625 | — | 125,001(D) | View → |
| Feb 22, 2026 | Feb 25 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | — | 45,000(D) | View → |
| Feb 21, 2026 | Feb 25 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 6,250 | — | 75,000(D) | View → |
| Feb 21, 2026 | Feb 25 12:44 AM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 23,250 | — | 279,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:43 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Option Exercise | 3,125 | — | 28,125(D) | View → |
| Feb 21, 2026 | Feb 25 12:43 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Option Exercise | 3,750 | — | 45,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:42 AM | Nicole SweenyChief Commercial Officer | Option Exercise | 5,000 | — | 45,000(D) | View → |
| Feb 21, 2026 | Feb 25 12:42 AM | Nicole SweenyChief Commercial Officer | Option Exercise | 6,250 | — | 75,000(D) | View → |
| Feb 21, 2026 | Feb 25 12:42 AM | Brian PiekosChief Financial Officer | Option Exercise | 5,000 | — | 60,000(D) | View → |
| Feb 17, 2026 | Feb 20 12:45 AM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 2,419 | — | 2,419(D) | View → |